1 Lonser RR,Glenn GM,Walther M,et al.von Hippel-Lindau disease[J].Lancet,2003,361(9374):2059-2067. 2 Maxwell PH,Wiesener MS,Chang GW,et al.The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis[J].Nature,1999,399(6733):271-275. 3 Yang H,Minamishima YA,Yan Q,et al.pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2[J].Mol Cell,2007,28(1):15-27. 4 Kurban G,Duplan E,Ramlal N,et al.Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2[J].Oncogene,2008,27(7):1004-1012. 5 Wang J,Ma Y,Jiang H,et al.Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice[J].J Hepatol,2011,55(2):359-368. 6 Giles RH,Lolkema MP,Snijckers CM,et al.Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis[J].Oncogene,2006,25(21):3065-3070. 7 Karanikas M,Esebidis A.Increasing incidence of colon cancer in patients <50 years old:a new entity[J].Ann Transl Med,2016,4(9):164-172. 8 Kelly ME,Spolverato G,Lê GN,et al.Synchronous colorectal liver metastasis:a network meta-analysis review comparing classical,combined,and liver-first surgical strategies[J].J Surg Oncol,2015,111(3):341-351. 9 Sonoshita M,Takaku K,Sasaki N,et al.Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716)knockout mice[J].Nat Med,2001,7(9):1048-1051. 10 Arber N,Eagle CJ,Spicak J,et al.Celecoxib for the prevention of colorectal adenomatous polyps[J].N Engl J Med,2006,355(9):885-895. 11 Sanchez-Lopez E,Flashner-Abramson E,Shalapour S,et al.Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling[J].Oncogene,2016,35(20):2634-244. 12 Bodur C,Kutuk O,Karsli-Uzunbas G,et al.Pramanicin analog induces apoptosis in human colon cancer cells:critical roles for Bcl-2,Bim,and p38 MAPK signaling[J].PLoS One,2013,8(2):e56369. 13 Struckmann K,Mertz K,Steu S,et al.pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma[J].J Pathol,2008,214(4):464-471. 14 Mroczko B,Groblewska M,Okulczyk B,et al.The diagnostic value of matrix metalloproteinase 9(MMP-9)and tissue inhibitor of matrix metalloproteinases 1(TIMP-1)determination in the sera of colorectal adenoma and cancer patients[J].Int J Colorectal Dis,2010,25(10):1177-1184. 15 Ishizaki T,Katsumata K,Tsuchida A,et al.Etodolac,a selective cyclooxygenase-2 inhibitor,inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity[J].Int J Mol Med,2006,17(2):357-362. |